New early detection methods can mean significantly improved outcomes for patients. Our researchers are at the forefront of this ground-breaking work.
Did you know?

Every 90 minutes a New Zealander dies from heart disease

Early detection can mean the difference between life and death.

Maori and Pacific people both have disproportionately poor health outcomes compared with the rest of the population.

Maori people constitute 14.5% of New Zealand's 4.3 million population, and Pacific people make up 6.9% of the population. 1

Cardiovascular disease (heart, stroke and blood vessel disease) is the leading cause of death in New Zealand

And accounts for 30% of deaths annually.

How our research is detecting heart disease

Early detection giving new hope

Our Clinical Research Group has developed a new early detection method for pulmonary vascular disease – or high blood pressure in the lungs – a severe condition affecting young adults.

4-dimensional flow magnetic resonance imaging

Heart failure is generally only clinically apparent once the disease process is advanced, leaving the clinician with limited treatment options. The Cardiac Imaging Group is developing 4-dimensional flow magnetic resonance imaging (4D-flow MRI), technology that is set to revolutionise not just cardiac imaging, but the daily practice of cardiology.